While society has thought of aging as an inevitable time-driven continuum, we increasingly recognize that many disease-related aging processes are druggable biological processes of senescence, Calimport's proposal is a bridge to growth in drug development in aging-related disease
Dr Stuart Calimport et al today propose the adoption of a systematic and comprehensive approach to the classification and staging of senescence and aging-related disease to guide policy and enable the aging-related medicine revolution. Read it in Science.